Crinetics Pharmaceuticals logo
Crinetics Pharmaceuticals CRNX
$ 53.4 1.25%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Crinetics Pharmaceuticals EBITDA per Share 2011-2024 | CRNX

Annual EBITDA per Share Crinetics Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.81 -3.21 -2.78 -2.43 -2.19 -2.33 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.19 -3.81 -2.79

Quarterly EBITDA per Share Crinetics Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -1.01 - - - -0.88 - -0.8 -0.81 -0.7 - -0.71 -0.69 -0.69 - -0.54 -0.52 -0.72 - -0.6 -0.53 -0.41 - -0.39 -2.41 -2.93 - -1.6 -1.18 - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.39 -2.93 -0.954